Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Bullboard - Stock Discussion Forum BioVaxys Technology Corp. C.BIOV

Alternate Symbol(s): BVAXF

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical... see more

CSE:BIOV - Post Discussion

BioVaxys Technology Corp. > BIOV~ARE YA TELLING SHAREHOLDERS SP WILL BE @.50 JAN26/2023

View:

Post by moneywagon on Aug 10, 2022 8:44am

BIOV~ARE YA TELLING SHAREHOLDERS SP WILL BE @.50 JAN26/2023

C.BIOV | 12 hours ago

VANCOUVER, BC, Aug. 9, 2022 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV, FRA: 5LB, OTCQB: BVAXF) ("BioVaxys" or the "Company") announces that it has extended the expiry date of 4,483,689 share purchase warrants with an exercise price of $0.50 and expiry date of August 26, 2022 and 1,477,291 share purchase warrants with an exercise price of $0.50 and an expiry date of September 3, 2022 (the "Warrants") that were issued pursuant to private placements that closed on August 26, 2020 and September 3, 2020, respectively. The Warrants amended expiry date is January 26, 2023.